Unknown

Dataset Information

0

Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.


ABSTRACT: Heat shock protein 90 (Hsp90) facilitates the maturation of many newly synthesized and unfolded proteins (clients) via the Hsp90 chaperone cycle, in which Hsp90 forms a heteroprotein complex and relies upon cochaperones, immunophilins, etc., for assistance in client folding. Hsp90 inhibition has emerged as a strategy for anticancer therapies due to the involvement of clients in many oncogenic pathways. Inhibition of chaperone function results in client ubiquitinylation and degradation via the proteasome, ultimately leading to tumor digression. Small molecule inhibitors perturb ATPase activity at the N-terminus and include derivatives of the natural product geldanamycin. However, N-terminal inhibition also leads to induction of the pro-survival heat shock response (HSR), in which displacement of the Hsp90-bound transcription factor, heat shock factor-1, translocates to the nucleus and induces transcription of heat shock proteins, including Hsp90. An alternative strategy for Hsp90 inhibition is disruption of the Hsp90 heteroprotein complex. Disruption of the Hsp90 heteroprotein complex is an effective strategy to prevent client maturation without induction of the HSR. Cucurbitacin D, isolated from Cucurbita texana, and 3-epi-isocucurbitacin D prevented client maturation without induction of the HSR. Cucurbitacin D also disrupted interactions between Hsp90 and two cochaperones, Cdc37 and p23.

SUBMITTER: Hall JA 

PROVIDER: S-EPMC5892428 | biostudies-literature | 2015 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.

Hall Jessica A JA   Seedarala Sahithi S   Rice Nichole N   Kopel Lucas L   Halaweish Fathi F   Blagg Brian S J BS  

Journal of natural products 20150310 4


Heat shock protein 90 (Hsp90) facilitates the maturation of many newly synthesized and unfolded proteins (clients) via the Hsp90 chaperone cycle, in which Hsp90 forms a heteroprotein complex and relies upon cochaperones, immunophilins, etc., for assistance in client folding. Hsp90 inhibition has emerged as a strategy for anticancer therapies due to the involvement of clients in many oncogenic pathways. Inhibition of chaperone function results in client ubiquitinylation and degradation via the pr  ...[more]

Similar Datasets

| S-EPMC5921262 | biostudies-literature
| S-EPMC3574928 | biostudies-literature
| S-EPMC7430654 | biostudies-literature
| S-EPMC2234240 | biostudies-literature
| S-EPMC6704453 | biostudies-literature
| S-EPMC1271799 | biostudies-literature
| S-EPMC10529509 | biostudies-literature
| S-EPMC3927929 | biostudies-literature
| S-EPMC3854018 | biostudies-literature
| S-EPMC6719599 | biostudies-literature